SCHEMBL14881202

SCHEMBL14881202

O=C(NOCc1ccccc1)c1cc(NS(=O)(=O)Cc2ccc(F)cc2)ccn1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.50
▸ AR P10275 2/20 0.45
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ ANO1 Q5XXA6 1/20 0.41
▸ NAMPT P43490 1/20 0.41
▸ HPGD P15428 2/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.40
▸ HDAC1 Q13547 1/20 0.39
▸ POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14881098 0.90 GRM4 (0.44) KMT2AARCA1CA2ANO1
SCHEMBL18135095 0.84 HPGD (0.47) KMT2AARHPGDKDM4EALDH1A1
SCHEMBL14882659 0.82 ANO1 (0.47) KMT2AANO1NAMPTHPGDNPC1
SCHEMBL18135112 0.81 ANO1 (0.49) KMT2AANO1NAMPTNPC1ALDH1A1
SCHEMBL14875894 0.79 HDAC1 (0.56) KMT2AARCA1CA2HPGD
SCHEMBL14876084 0.79 KMT2A (0.51) KMT2AARNAMPTHPGDKDM4E
SCHEMBL18135116 0.78 HPGD (0.52) KMT2AARHPGDKDM4EALDH1A1
Hydrochloric Acid SCHEMBL14876520 0.78 KMT2A (0.50) KMT2ANAMPTHPGDKDM4EALDH1A1
SCHEMBL28823850 0.78 HPGD (0.53) KMT2AARCA1CA2HPGD
SCHEMBL14875819 0.76 ALDH1A1 (0.52) KMT2AARHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2776396-A2 HETEROARYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE F.HOFFMANN-LA ROCHE AG (CH) 2014-09-17 — — EP disclosed
WO-2013057251-A2 HETEROARYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2013-04-25 — — WO disclosed
Send feedback